Literature DB >> 28822225

Altered thymocyte and T cell development in neonatal mice with hyperoxia-induced lung injury.

Sowmya Angusamy1, Tamer Mansour2,3, Mohammed Abdulmageed1,4, Rachel Han1, Brian C Schutte2, John LaPres5, Jack R Harkema6, Said A Omar1,7.   

Abstract

BACKGROUND: The adaptive immune system of neonates is relatively underdeveloped. The thymus is an essential organ for adaptive T cell development and might be affected during the natural course of oxygen induced lung injury. The effect of prolonged hyperoxia on the thymus, thymocyte and T cell development, and its proliferation has not been studied extensively.
METHODS: Neonatal mice were exposed to 85% oxygen (hyperoxia) or room air (normoxia) up to 28 days. Flow cytometry using surface markers were used to assay for thymocyte development and proliferation.
RESULTS: Mice exposed to prolonged hyperoxia had evidence of lung injury associated alveolar simplification, a significantly lower mean weight, smaller thymic size, lower mean thymocyte count and higher percentage of apoptotic thymocytes. T cells subpopulation in the thymus showed a significant reduction in the count and proliferation of double positive and double negative T cells. There was a significant reduction in the count and proliferation of single positive CD4+ and CD8+ T cells.
CONCLUSIONS: Prolonged hyperoxia in neonatal mice adversely affected thymic size, thymocyte count and altered the distribution of T cells sub-populations. These results are consistent with the hypothesis that prolonged hyperoxia causes defective development of T cells in the thymus.

Entities:  

Keywords:  Hyperoxia; T cells; neonatal; thymocyte development; thymus

Mesh:

Year:  2018        PMID: 28822225     DOI: 10.1515/jpm-2016-0234

Source DB:  PubMed          Journal:  J Perinat Med        ISSN: 0300-5577            Impact factor:   1.901


  4 in total

1.  Macrophage-derived IL-6 trans-signalling as a novel target in the pathogenesis of bronchopulmonary dysplasia.

Authors:  Dharmesh Hirani; Cristina M Alvira; Soula Danopoulos; Carlos Milla; Michele Donato; Lu Tian; Jasmine Mohr; Katharina Dinger; Christina Vohlen; Jaco Selle; Silke V Koningsbruggen-Rietschel; Verena Barbarino; Christian Pallasch; Stefan Rose-John; Margarete Odenthal; Gloria S Pryhuber; Siavash Mansouri; Rajkumar Savai; Werner Seeger; Purvesh Khatri; Denise Al Alam; Jörg Dötsch; Miguel A Alejandre Alcazar
Journal:  Eur Respir J       Date:  2022-02-17       Impact factor: 33.795

Review 2.  Stem-Cell Therapy for Bronchopulmonary Dysplasia (BPD) in Newborns.

Authors:  Said A Omar; Amal Abdul-Hafez; Sherif Ibrahim; Natasha Pillai; Mohammed Abdulmageed; Ranga Prasanth Thiruvenkataramani; Tarek Mohamed; Burra V Madhukar; Bruce D Uhal
Journal:  Cells       Date:  2022-04-09       Impact factor: 7.666

3.  Mesenchymal Stromal Cell-Derived Extracellular Vesicles Restore Thymic Architecture and T Cell Function Disrupted by Neonatal Hyperoxia.

Authors:  Monica Reis; Gareth R Willis; Angeles Fernandez-Gonzalez; Vincent Yeung; Elizabeth Taglauer; Margaret Magaletta; Teagan Parsons; Alan Derr; Xianlan Liu; Rene Maehr; Stella Kourembanas; S Alex Mitsialis
Journal:  Front Immunol       Date:  2021-04-15       Impact factor: 7.561

Review 4.  Inborn Errors of Immunity in the Premature Infant: Challenges in Recognition and Diagnosis.

Authors:  Scott M Gordon; Amy E O'Connell
Journal:  Front Immunol       Date:  2021-12-24       Impact factor: 8.786

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.